Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Matthew Lavery

Orthopaedic Surgery Greenwood, IN Medical Doctor

NPI 1295943678 CMS profile 149802

1260 Innovation Pkwy, #100, Greenwood, IN 46143

Open in the dashboard

General payments

$9,763

38 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$53,154 paid to institutions, not to them · program years 2019–2025

Through program year 2024, Matthew Lavery of Greenwood, IN is reported in the CMS Open Payments database as having received $9,763 across 38 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $53,154 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $203 5
2022 General $309 7
2021 General $8,628 21
2020 General $103 4
2019 General $520 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Lavery
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Lavery were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Matthew Lavery Orthopaedic Surgery median Middle half National median
2019 $520 $644 $140–$2,844 $163
2020 $103 $312 $75–$1,860 $114
2021 $8,628 $520 $117–$2,495 $132
2022 $309 $598 $128–$2,731 $149
2023 $0 $461 $128–$2,264 $160
2024 $203 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. DePuy Synthes Products, Inc. $6,395 6 payments
  2. Encore Medical, LP $1,955 9 payments
  3. Medical Device Business Services, Inc. $533 10 payments
  4. Crossroads Orthopedics, LLC $520 1 payment
  5. DePuy Synthes Sales Inc. $152 3 payments
  6. Medacta USA, Inc. $145 6 payments
  7. Zimmer Biomet Holdings, Inc. $38 1 payment
  8. Ossur Americas., Inc $26 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $7,739 2 payments
  2. Food and Beverage $978 28 payments
  3. Travel and Lodging $527 7 payments
  4. Education $520 1 payment
Products named General payments · program years 2019–2024
  1. VAPR $6,717 11 payments
  2. DJO SURGICAL Joint Implants $277 5 payments
  3. DJO SURGICAL Joint Implants $177 3 payments
  4. DYNACORD $152 3 payments
  5. PRIMARY SHOULDER $117 5 payments
  6. Comprehensive Reverse $38 1 payment
  7. AMISTEM $27 1 payment
  8. Miami J $26 2 payments
  9. FMS $5 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$75,529

Of which drugs: $416

Medicare patients

253

Average age 72

Services billed

4,520

146 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 68%
Depression 32%
Diabetes 23%
Ischemic heart disease 22%
Chronic kidney disease 17%
Atrial fibrillation 14%
Osteoporosis 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 43 3,840 $361

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record